R&D Tax Incentive Received
R&D Tax Incentive Received
Brisbane, Jan 18, 2018 AEST (ABN Newswire) - Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $1,230,329 from the Australian Taxation Office under the Federal Government's Research and Development (R&D) Tax Incentive scheme.

The refund is from Anatara's 2016-2017 research activities and reflects a period of significant investment into the Company's lead product, Detach(R), for the control of gastrointestinal disease in pigs, as well as activities designed to progress Anatara's human therapeutics pipeline.

Anatara's Chairman and CEO, Dr Mel Bridges said, "The 2016-2017 period was an important one for Anatara as we focused on moving Detach closer to market and prepared to expand our program into human applications. The R&D tax incentive provides an important source of non-dilutive funding and enables the Company to remain well funded as we progress our commercialisation activities."

About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) develops and aims to partner non-antibiotic, oral products for gastrointestinal diseases in animals and humans where there is significant unmet need and large market opportunity. In May 2018, Anatara granted an exclusive licence to the leading global animal health company, Zoetis Inc., for the worldwide development, manufacturing, distribution and marketing of its lead product Detach as a non-antibiotic approach to aid in the control of diarrhoeal disease (known as scour) in livestock and in horses. Anatara is now focused on developing its human product pipeline for gastrointestinal health applications. For more information, please visit www.anataralifesciences.com.



Investor inquiries:
Dr Mel Bridges
Chairman & CEO, Anatara Lifesciences
Phone: +61-413-051-600
Email: mbridges@anatara.com

Media inquiries:
Jane Lowe
Managing Director, IR Department
Phone: +61-411-117-774
Email: jane.lowe@irdepartment.com.au

Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 46) (Last 30 Days: 204) (Since Published: 3584) 

Anatara Lifesciences Ltd NEWS: RECENT VISITS (5356)

Research Report

Social Media